Datopotamab Deruxtecan trials for Breast cancer

All Datopotamab Deruxtecan trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Datopotamab Deruxtecan for Breast cancer

• DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
  NCT06176261 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
  NCT01042379 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 42 locations
• Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response
  NCT07582887 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease
  NCT07069595 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases
  NCT05866432 · Phase: Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Datopotamab Deruxtecan for Breast cancer?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.